FDA Approves Oral Drug Mayzent to Treat Multiple Sclerosis, Novartis
The U.S. Food and Drug Administration (FDA) has approved Mayzent tablets (siponimod) by Novartis for the treatment of Multiple Sclerosis ...
The U.S. Food and Drug Administration (FDA) has approved Mayzent tablets (siponimod) by Novartis for the treatment of Multiple Sclerosis ...
© 2025 Higher Education Plus
Need Help